Results 101 to 110 of about 223,964 (346)

Advances in Bioprinting to Model Immune‐Mediated Skin Diseases

open access: yesAdvanced Healthcare Materials, EarlyView.
This review explores how 3D bioprinting drives innovation in developing in vitro skin models that mimic immune‐mediated diseases. It highlights current technologies, key applications in studying skin pathologies, and emerging challenges. The review points toward future opportunities for improving disease modeling and advancing therapeutic and cosmetic ...
Andrea Ulloa‐Fernández   +4 more
wiley   +1 more source

Antinomic natural self-protection mechanism in long-lasting woods: a case study with three tropical species from French Guiana [PDF]

open access: yes, 2009
We demonstrate in this work through 3 examples that Amazonian trees may specialize longlasting woods by means of at least to different approaches. Wallaba impregnates its wood with large amounts of weakly antifungal compounds acting in synergy, while ...
Amusant, Nadine   +9 more
core  

First hospital outbreak of the globally emerging Candida auris in a European hospital [PDF]

open access: yes, 2016
Background: Candida auris is a globally emerging multidrug resistant fungal pathogen causing nosocomial transmission. We report an ongoing outbreak of C. auris in a London cardio-thoracic center between April 2015 and July 2016.
Abdolrasouli, A   +11 more
core   +2 more sources

Redefining Therapies for Drug‐Resistant Tuberculosis: Synergistic Effects of Antimicrobial Peptides, Nanotechnology, and Computational Design

open access: yesAdvanced Healthcare Materials, EarlyView.
Antimicrobial peptide (AMP)‐loaded nanocarriers provide a multifunctional strategy to combat drug‐resistant Mycobacterium tuberculosis. By enhancing intracellular delivery, bypassing efflux pumps, and disrupting bacterial membranes, this platform restores phagolysosome fusion and macrophage function.
Christian S. Carnero Canales   +11 more
wiley   +1 more source

MEDICINAL PLANTS AND BIOLOGICALLY ACTIVE SUBSTANCES WITH ANTIFUNGAL PROPERTIES

open access: yesФундаментальная и клиническая медицина, 2017
Fungal diseases, caused by pathogenic fungi from air, soil, water, plants, and even the human body, are dangerous for humans of all age groups. Currently, commercially available antifungal agents mainly include synthetic products having numerous ...
ANDREY A. Mar‘In, NATALIA E. Kolomiets
doaj  

Influence of subinhibitory antifungal concentrations on extracellular hydrolases and biofilm production by Candida albicans recovered from Egyptian patients

open access: yesBMC Infectious Diseases, 2019
Background Extracellular hydrolases (phospholipase, aspartyl protease and haemolysin) and biofilm production are considered as major virulence factors of the opportunistic pathogenic fungus Candida albicans.
Houdaii H. El-Houssaini   +3 more
doaj   +1 more source

Safety and Pharmacokinetics of Intravenous and Oral Fosmanogepix, a First-in-Class Antifungal Agent, in Healthy Volunteers

open access: hybrid, 2023
Michael R. Hodges   +8 more
openalex   +1 more source

Skin‐Interfaced Therapeutic Patches for Wound Fluid Management and Transdermal Drug Delivery

open access: yesAdvanced Healthcare Materials, EarlyView.
This study presents an integrated skin‐interfaced device combining microfluidics, hydrogel film technology, flexible electronics, and iontophoresis‐based transdermal delivery of PDRN to enhance wound healing. The device effectively manages wound fluid, maintains optimal moisture, and non‐invasively delivers therapeutic drugs.
Dongjun Han   +5 more
wiley   +1 more source

Antifungal activity of redox-active benzaldehydes that target cellular antioxidation

open access: yesAnnals of Clinical Microbiology and Antimicrobials, 2011
Background Disruption of cellular antioxidation systems should be an effective method for control of fungal pathogens. Such disruption can be achieved with redox-active compounds.
Mahoney Noreen   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy